Product Specifications
| Specification | Details |
| Manufacturer / Brand | Organon LLC |
| Manufacturer # / SKU | 78206011801 |
| NDC Number | 78206-0118-01 |
| Active Ingredients | Betamethasone Sodium Phosphate & Betamethasone Acetate |
| Strength | 6 mg / mL (3 mg of each ester) |
| Volume per Unit | 5 mL |
| Container Type | Multi-Dose Vial (MDV) |
| Formulation | Sterile Aqueous Suspension |
| Latex Content | Not made with natural rubber latex |
| Storage | Store at 25°C (77°F); Protect from light |
Key Features
-
Dual-Release Technology: Provides “prompt and prolonged” activity. The sodium phosphate starts working quickly, while the acetate provides a reservoir for continued relief.
-
Versatile Administration: Indicated for Intramuscular (IM), Intra-articular (joint), Intralesional (skin), and soft tissue injection.
-
Powerful Anti-Inflammatory: A derivative of prednisolone, betamethasone offers potent activity with reduced mineralocorticoid (salt-retaining) effects.
-
Ready-to-Use Suspension: Supplied as a sterile aqueous suspension; requires thorough shaking before administration to ensure uniform dosage.
Clinical Applications
-
Rheumatic Disorders: Adjunctive therapy for acute gouty arthritis, bursitis, and tenosynovitis.
-
Allergic States: Management of severe asthma, contact dermatitis, and drug hypersensitivity.
-
Dermatologic Diseases: Treatment of keloids, psoriatic plaques, and alopecia areata.
-
Endocrine Disorders: Primary or secondary adrenocortical insufficiency (when used with mineralocorticoids).
⚠️ Black Box & Safety Warnings: Do not administer intravenously. Serious neurological events, some resulting in death, have been reported with epidural injection.
⚠️ Usage Note: Shake well before using. The suspension must be uniform to ensure the patient receives the correct ratio of fast-acting to long-acting esters.
⚠️ Contraindications: Contraindicated in systemic fungal infections and patients with known hypersensitivity to betamethasone or other corticosteroids.
